Checkpoint Therapeutics Profit Margin 2016-2021 | CKPT
Current and historical gross margin, operating margin and net profit margin for Checkpoint Therapeutics (CKPT) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Checkpoint Therapeutics net profit margin as of September 30, 2021 is -13311.47%.
|Checkpoint Therapeutics Annual Profit Margins
|Checkpoint Therapeutics Quarterly Profit Margins
||Medical - Biomedical and Genetics
Checkpoint Therapeutics, Inc. is a clinical stage, immuno oncology biopharmaceutical. It focused on the acquisition, development and commercialization of non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Checkpoint Therapeutics, Inc. is headquartered in New York City.